1.
Bioorg Med Chem Lett
; 12(23): 3483-6, 2002 Dec 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12419389
RESUMO
A series of novel, highly potent alpha(v)beta(3) receptor antagonists with favorable pharmacokinetic profiles has been identified. In this series of antagonists, 2-aryl beta-amino acids function as potent aspartic acid replacements.